tags

PFAS
Chemical
PFAS Regulatory Wave: Compliance Challenges & Solutions for Medical Devices

Per- and Polyfluoroalkyl Substances (PFAS), commonly known as "forever chemicals", feature extremely stable carbon-fluorine bonds, high bioaccumulation potential and suspected endocrine disrupting properties, leading to stringent regulatory restrictions worldwide. According to OECD statistics, the PFAS family comprises over 10,000 substances. Fluoropolymers including Polytetrafluoroethylene (PTFE), FEP, PFA, PVDF and PCTFE are widely applied in cardiovascular catheters, implant coatings, pacemaker wire insulation, as well as sterile high-barrier packaging for medical devices.

ECHA Releases PFAS Draft Use Mapping

On November 5, 2025, the European Chemicals Agency (ECHA) published mapping of PFAS uses, serving as an industry support document for the upcoming public consultation on PFAS restrictions. The mapping systematically outlines PFAS applications across 14 major industrial, professional, and consumer sectors, including battery manufacturing, textiles, electronics, and PFAS production.

EU REACH Amendment Adds PFAS Control Provisions

On October 3, 2025, the European Commission published (EU) 2025/1988 in the Official Journal, amending Annex XVII of the REACH Regulation (Restrictions) to include item 82, which sets forth control requirements for PFAS in firefighting foams. The revised regulation will take effect on October 23, 2025. This amendment marks a significant step towards comprehensive PFAS regulation in the EU. The firefighting foam industry should pay close attention to this revision, and other industries should continue to monitor the EU's progress in regulating PFAS across all sectors.